EGFR and non-small cell lung carcinoma: Pts with EGFR-mutated advanced NSCLC who progressed after osimertinib and platinum-based chem;Amiv subcutaneous combined with Lazertinib, N=206; Amiv intravenous combined with Lazertinib, N=212;